Other cancer types analysed show no significant difference in RIF1 expression, including bladder (BLCA), kidney (KIRC), liver (LIHC), prostate (PRAD), and, interestingly, breast cancer (BRCA), despite a previous report suggesting RIF1 is highly expressed in malignant breast tumour sections [7]. Here, RIF1 is linked to cancer.